UBS lowered the firm’s price target on Corteva (CTVA) to $85 from $91 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Apple downgraded, Alibaba upgraded: Wall Street’s top analyst calls
- Corteva downgraded to Sector Weight from Overweight at KeyBanc
- Nike upgraded, RH downgraded: Wall Street’s top analyst calls
- Corteva’s Strategic Split: Unlocking Shareholder Value with a Buy Rating
- Corteva’s Strategic Spin-Off and Market Challenges: A Hold Rating Amid Investor Concerns